It's doubtful it will help, but it certainly wouldn't hurt.
Rock Creek has to straighten out their regulatory hurdles before anything else. A partnership anytime soon -- at this clinical stage, at these prices -- would have horrendous terms. They need some organically good news, and soon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.